Form 4: COMPASS Pathways Director Linda McGoldrick Granted 26,000 Share Options

COMPASS Pathways plc Director Linda McGoldrick was granted 26,000 share options with an exercise price of $4.52, vesting by June 2026.

Summary

• Linda McGoldrick, a Director of COMPASS Pathways plc, was granted 26,000 share options on June 12, 2025.
• The granted options have an exercise price of $4.52 per Ordinary Share.
• These options will vest in full upon the earlier of June 12, 2026 (the first anniversary of the grant date) or the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.
• The options are exercisable until their expiration date of June 11, 2035.
• Each share option represents the right to buy one Ordinary Share, which may be represented by an American Depositary Share (ADS).

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to a director, which is generally viewed as a positive for aligning management incentives with shareholder interests, without indicating any negative operational or financial news.

Positives

• The grant of share options to Director Linda McGoldrick aligns her interests with those of shareholders, incentivizing long-term company performance and value creation.

Negatives

• No direct negatives are identified in this Form 4 filing, as it reports a routine option grant rather than a sale or adverse event.

Risks

• No specific risks are detailed in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future outlook, as it is solely a report of an insider's equity transaction.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context. However, equity grants to directors are a common practice across industries, including the biotechnology and pharmaceutical sectors where COMPASS Pathways plc operates, serving to align leadership incentives with shareholder value.

Comparison to Industry Standards

• This Form 4 filing does not provide specific data for direct comparison to industry-standard compensation benchmarks or project results. The grant of share options to a director is a standard practice for executive and board compensation across publicly traded companies.

Related Party Transactions

• The grant of 26,000 share options to Linda McGoldrick, a Director of COMPASS Pathways plc, constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: The grant of options to a director can align management's long-term interests with shareholder value creation, potentially leading to improved company performance.
• Employees: No direct impact on general employees is mentioned in this filing.

Next Steps

• The granted share options will vest in full on the earlier of June 12, 2026, or the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.

Key Dates

Keywords

COMPASS Pathways, CMPS, Form 4, insider transaction, share options, stock options, director compensation, equity grant, beneficial ownership